Novartis AG Cash on Hand 2010-2024 | NVS

Novartis AG cash on hand for the quarter ending December 31, 2024 was $13.457B, a 6.73% decline year-over-year.

  • Novartis AG cash on hand for 2024 was $13.457B, a 6.73% decline from 2023.
  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.

Novartis AG Cash on Hand 2010-2024 | NVS

  • Novartis AG cash on hand for 2024 was $13.457B, a 6.73% decline from 2023.
  • Novartis AG cash on hand for 2023 was $14.428B, a 23.78% decline from 2022.
  • Novartis AG cash on hand for 2022 was $18.93B, a 33.18% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
Novo Nordisk (NVO)$375.8B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B